Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. META

Go back to Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA
Eisai Co Ltd (AMEX: ESALF) Delayed: 23.88 --0 (-0%)
Previous Close $23.88    52 Week High $66.25 
Open $23.88    52 Week Low $53.50 
Day High $23.88    P/E N/A 
Day Low $23.88    EPS $0.00 
Volume 3,798       

Eisai Co Ltd American Depositary Shares (AMEX: ESALY) Delayed: 61.51 --0 (-0%)
Previous Close $61.51    52 Week High $67.60 
Open $49.73    52 Week Low $53.55 
Day High $61.51    P/E N/A 
Day Low $61.51    EPS $0.00 
Volume 1,907,007       

Merck & Co. (NYSE: MRK) Delayed: 119.05 -1.71 (1.42%)
Previous Close $120.76    52 Week High $65.46 
Open $121.50    52 Week Low $47.97 
Day High $121.90    P/E 80.99 
Day Low $118.83    EPS $1.47 
Volume 10,927,028